REVIEW

The trouble with antibiotics

About authors

Yaroslavl State Medical University, Yaroslavl, Russia

Correspondence should be addressed: Shamil Kh. Palyutin
ul. Revolutsionnaya, 5, Yaroslavl, 150000, Russia; ur.xednay@ocimahs

About paper

Author contribution: Speshilova SA — research planning, data collection, data analysis, data interpretation, preparing a manuscript draft, article concept, literature selection and analysis, data generalization, text writing; Sinitsina OA — research planning, data selection and analysis; Demarina SM — preparing a list of literature; Palyutin ShKh — literature selection and analysis, data generalization, text writing.

Received: 2022-12-21 Accepted: 2023-01-20 Published online: 2023-02-25
|

During the long history of antibiotics, resistance of causative agents of main infectious diseases was estimated as a very serious threat to effective treatment of patients and as a social and economic problem faced by the entire mankind. The activities performed by the medical society provided no significant effect resulting in growing antibiotic resistance. The pandemic of novel coronavirus infection only made things worse. It became a new challenge for the medical community regarding searching solutions which are clinical, organizational and methodological by nature in the global struggle with resistance to antibiotics. The reviews of several studies of coronaviral infections have shown that treatment with antibiotics failed to correlate with the decreased all-cause mortality. In this work, we have reviewed some aspects of therapy with antibiotics, including ethical ones. Ethical aspects of antibiotic therapy concern decisions of physicians about administration of commonly unnecessary antimicrobial agents.

Keywords: antibiotic resistance, COVID-19, ethics, antibiotics, antibiotic therapy

КОММЕНТАРИИ (0)